Proinflammatory responses to lipo-oligosaccharide of Neisseria meningitidis immunotype strains in relation to virulence and disease

Journal of Infectious Diseases

Volumn 185, Issue 10, 2002, Pages 1431-1438

  Braun, Jan M ^a,b   Blackwell, Caroline C ^a   Poxton, Ian R ^a   El Ahmer, Omar ^a   Gordon, Ann E ^a   Al Madani, Osama M ^a   Weir, Donald M ^a,b   Giersen, Sonja ^b   Beuth, Josef ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; COLECALCIFEROL; CYTOKINE; ENDOTOXIN; EPITOPE; INTERLEUKIN 6; LIPID A; LIPOOLIGOSACCHARIDE; OLIGOSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL LINE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; HUMAN; HUMAN CELL; INFLAMMATION; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SERUM;

ANIMALS; ANTIBODIES, BACTERIAL; CELL LINE; CHOLECALCIFEROL; ENDOTOXINS; EPITOPES; HUMANS; IMMUNE SERA; INTERLEUKIN-6; LIPID A; LIPOPOLYSACCHARIDES; MENINGOCOCCAL INFECTIONS; MICE; MONOCYTES; NEISSERIA MENINGITIDIS; NEUTRALIZATION TESTS; OLIGOSACCHARIDES; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 0037093997     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340501     Document Type: Article

References (51)

1. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease
2. Release of tumor necrosis factor: An innate host characteristic that may contribute to the outcome of meningococcal disease
3. Genetic influence on cytokine production and fatal meningococcal disease
4. Immunological properties of meningococcal lipopolysaccharide from serogroups A, B & C
5. Bacteremia and compartmentalization of LPS in meningococcal disease
6. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections
7. Immunological surrogate parameters in a prognostic model for multi-organ failure and death
8. Prospectively validated prediction of organ failure and hypotension in patients with septic shock: The Systemic Mediator Associated Response Test (SMART)
9. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity
10. Relation between cytokines and routine laboratory data in children with septic shock and purpura
11. Current status of meningococcal group B vaccine candidates: Capsular or noncapsular?
12. The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis
13. Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid phase radioimmunoassay
14. Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin)
15. Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose
16. Complement factor deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis
17. The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis
18. Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model
19. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis
20. Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis
21. Colony variants of Neisseria meningitidis strain 2996 (B:2b:P1.2): Influence of class-5 outer membrane proteins and lipopolysaccharides
22. The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis
23. Cortisol levels and control of inflammatory responses to toxic shock syndrome toxin-1 (TSST-1): The prevalence of night-time deaths in sudden infant death syndrome (SIDS)
24. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease
25. Variation in the tumor necrosis factor-α gene promoter region may be associated with death from meningococcal disease
26. Infection with respiratory syncytial virus enhances expression of native receptors for non-pilate Neisseria meningitidis on HEp-2 cells
27. Why is cigarette smoke a risk factor for meningococcal disease? [poster 202]
28. Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies
29. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3
30. The role of vitamin D derivates and retinoids in the differentiation of human leukaemia cells
31. Bactericidal activity of a monocytic cell line (THP-1) against common respiratory tract bacterial pathogens is depressed after infection with respiratory syncytial virus
32. A rapid and sensitive method for quantitation of microgram quantities of protein utilising the principle of protein-dye binding
33. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes
34. Tumour necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species
35. Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis
36. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional detactivator of human monocytes
37. Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin
38. Toxicity and immunogenicity of Neisseria meningitis polysaccharide incorporated into liposomes
39. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes
40. Interactions of invasive and noninvasive strains of Neisseria meningitidis with monkey epithelial cells, mouse monocytes and human macrophages
41. Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells
42. Endotoxin liberation associated with growth, encapsulation and virulence of Neisseria meningitidis
43. Endotoxin liberated from Neisseria meningitidis isolated from carriers and clinical cases
44. Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shock
45. Intranasal infection of infant mice with Neisseria meningitidis
46. Structural characterization of the lipid A component of pathogenic Neisseria meningitidis
47. The chemical structure of bacterial endotoxin in relation to bioactivity
48. The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB contains L2, L3, and novel oligosaccharides, and lacks lipid-A 4′-phosphate substituent
49. NMB) mutant strain CMK 1 of Neisseria meningitidis: Implications for LOS inner core assembly and LOS-based vaccines